Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Radiation and Docetaxel in High Risk Localized Prostate Cancer
NCT00321698Phase 2Terminated
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Apr 2006
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in prostate cancer (PCa), sponsored by OHSU Knight Cancer Institute. Started Apr 2006; status: terminated.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00321698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321698.